Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice
Identifieur interne : 000568 ( Pmc/Corpus ); précédent : 000567; suivant : 000569Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice
Auteurs : Giovanni Di Minno ; Mariana Canaro ; James W. Ironside ; David Navarro ; Carlo Federico Perno ; Andreas Tiede ; Lutz GürtlerSource :
- Haematologica [ 0390-6078 ] ; 2013.
Url:
DOI: 10.3324/haematol.2013.084145
PubMed: 24091928
PubMed Central: 3789452
Links to Exploration step
PMC:3789452Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice</title><author><name sortKey="Di Minno, Giovanni" sort="Di Minno, Giovanni" uniqKey="Di Minno G" first="Giovanni" last="Di Minno">Giovanni Di Minno</name><affiliation><nlm:aff id="af1-0981495">Dipartimento di Medicina Clinica e Chirurgia, Centro di Coordinamento Regionale per le Emocoagulopatie, Napoli, Italy</nlm:aff></affiliation></author><author><name sortKey="Canaro, Mariana" sort="Canaro, Mariana" uniqKey="Canaro M" first="Mariana" last="Canaro">Mariana Canaro</name><affiliation><nlm:aff id="af2-0981495">Hemostasis and Thrombosis, Son Espases Universitary Hospital, Palma de Mallorca, Spain</nlm:aff></affiliation></author><author><name sortKey="Ironside, James W" sort="Ironside, James W" uniqKey="Ironside J" first="James W." last="Ironside">James W. Ironside</name><affiliation><nlm:aff id="af3-0981495">National Creutzfeldt-Jakob Disease Surveillance Unit, School of Clinical Sciences, University of Edinburgh, Western General Hospital, Edinburgh, UK</nlm:aff></affiliation></author><author><name sortKey="Navarro, David" sort="Navarro, David" uniqKey="Navarro D" first="David" last="Navarro">David Navarro</name><affiliation><nlm:aff id="af4-0981495">Microbiology Service, Hospital Clínico Universitaria and Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain</nlm:aff></affiliation></author><author><name sortKey="Perno, Carlo Federico" sort="Perno, Carlo Federico" uniqKey="Perno C" first="Carlo Federico" last="Perno">Carlo Federico Perno</name><affiliation><nlm:aff id="af5-0981495">Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy</nlm:aff></affiliation></author><author><name sortKey="Tiede, Andreas" sort="Tiede, Andreas" uniqKey="Tiede A" first="Andreas" last="Tiede">Andreas Tiede</name><affiliation><nlm:aff id="af6-0981495">Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany</nlm:aff></affiliation></author><author><name sortKey="Gurtler, Lutz" sort="Gurtler, Lutz" uniqKey="Gurtler L" first="Lutz" last="Gürtler">Lutz Gürtler</name><affiliation><nlm:aff id="af7-0981495">Max von Pettenkofer Institute for Hygiene and Medical Microbiology, University of München, Munich, Germany</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">24091928</idno><idno type="pmc">3789452</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789452</idno><idno type="RBID">PMC:3789452</idno><idno type="doi">10.3324/haematol.2013.084145</idno><date when="2013">2013</date><idno type="wicri:Area/Pmc/Corpus">000568</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000568</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice</title><author><name sortKey="Di Minno, Giovanni" sort="Di Minno, Giovanni" uniqKey="Di Minno G" first="Giovanni" last="Di Minno">Giovanni Di Minno</name><affiliation><nlm:aff id="af1-0981495">Dipartimento di Medicina Clinica e Chirurgia, Centro di Coordinamento Regionale per le Emocoagulopatie, Napoli, Italy</nlm:aff></affiliation></author><author><name sortKey="Canaro, Mariana" sort="Canaro, Mariana" uniqKey="Canaro M" first="Mariana" last="Canaro">Mariana Canaro</name><affiliation><nlm:aff id="af2-0981495">Hemostasis and Thrombosis, Son Espases Universitary Hospital, Palma de Mallorca, Spain</nlm:aff></affiliation></author><author><name sortKey="Ironside, James W" sort="Ironside, James W" uniqKey="Ironside J" first="James W." last="Ironside">James W. Ironside</name><affiliation><nlm:aff id="af3-0981495">National Creutzfeldt-Jakob Disease Surveillance Unit, School of Clinical Sciences, University of Edinburgh, Western General Hospital, Edinburgh, UK</nlm:aff></affiliation></author><author><name sortKey="Navarro, David" sort="Navarro, David" uniqKey="Navarro D" first="David" last="Navarro">David Navarro</name><affiliation><nlm:aff id="af4-0981495">Microbiology Service, Hospital Clínico Universitaria and Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain</nlm:aff></affiliation></author><author><name sortKey="Perno, Carlo Federico" sort="Perno, Carlo Federico" uniqKey="Perno C" first="Carlo Federico" last="Perno">Carlo Federico Perno</name><affiliation><nlm:aff id="af5-0981495">Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy</nlm:aff></affiliation></author><author><name sortKey="Tiede, Andreas" sort="Tiede, Andreas" uniqKey="Tiede A" first="Andreas" last="Tiede">Andreas Tiede</name><affiliation><nlm:aff id="af6-0981495">Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany</nlm:aff></affiliation></author><author><name sortKey="Gurtler, Lutz" sort="Gurtler, Lutz" uniqKey="Gurtler L" first="Lutz" last="Gürtler">Lutz Gürtler</name><affiliation><nlm:aff id="af7-0981495">Max von Pettenkofer Institute for Hygiene and Medical Microbiology, University of München, Munich, Germany</nlm:aff></affiliation></author></analytic><series><title level="j">Haematologica</title><idno type="ISSN">0390-6078</idno><idno type="eISSN">1592-8721</idno><imprint><date when="2013">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader></TEI><pmc article-type="editorial"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Haematologica</journal-id><journal-id journal-id-type="iso-abbrev">Haematologica</journal-id><journal-id journal-id-type="hwp">haematol</journal-id><journal-id journal-id-type="publisher-id">Haematologica</journal-id><journal-title-group><journal-title>Haematologica</journal-title></journal-title-group><issn pub-type="ppub">0390-6078</issn><issn pub-type="epub">1592-8721</issn><publisher><publisher-name>Ferrata Storti Foundation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24091928</article-id><article-id pub-id-type="pmc">3789452</article-id><article-id pub-id-type="doi">10.3324/haematol.2013.084145</article-id><article-id pub-id-type="publisher-id">0981495</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorials and Perspectives</subject></subj-group></article-categories><title-group><article-title>Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Di Minno</surname><given-names>Giovanni</given-names></name><xref ref-type="aff" rid="af1-0981495">1</xref><xref ref-type="corresp" rid="c1-0981495"></xref></contrib><contrib contrib-type="author"><name><surname>Canaro</surname><given-names>Mariana</given-names></name><xref ref-type="aff" rid="af2-0981495">2</xref></contrib><contrib contrib-type="author"><name><surname>Ironside</surname><given-names>James W.</given-names></name><xref ref-type="aff" rid="af3-0981495">3</xref></contrib><contrib contrib-type="author"><name><surname>Navarro</surname><given-names>David</given-names></name><xref ref-type="aff" rid="af4-0981495">4</xref></contrib><contrib contrib-type="author"><name><surname>Perno</surname><given-names>Carlo Federico</given-names></name><xref ref-type="aff" rid="af5-0981495">5</xref></contrib><contrib contrib-type="author"><name><surname>Tiede</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="af6-0981495">6</xref></contrib><contrib contrib-type="author"><name><surname>Gürtler</surname><given-names>Lutz</given-names></name><xref ref-type="aff" rid="af7-0981495">7</xref></contrib></contrib-group><aff id="af1-0981495"><label>1</label>Dipartimento di Medicina Clinica e Chirurgia, Centro di Coordinamento Regionale per le Emocoagulopatie, Napoli, Italy</aff><aff id="af2-0981495"><label>2</label>Hemostasis and Thrombosis, Son Espases Universitary Hospital, Palma de Mallorca, Spain</aff><aff id="af3-0981495"><label>3</label>National Creutzfeldt-Jakob Disease Surveillance Unit, School of Clinical Sciences, University of Edinburgh, Western General Hospital, Edinburgh, UK</aff><aff id="af4-0981495"><label>4</label>Microbiology Service, Hospital Clínico Universitaria and Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain</aff><aff id="af5-0981495"><label>5</label>Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy</aff><aff id="af6-0981495"><label>6</label>Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany</aff><aff id="af7-0981495"><label>7</label>Max von Pettenkofer Institute for Hygiene and Medical Microbiology, University of München, Munich, Germany</aff><author-notes><corresp id="c1-0981495">E-mail: <email>diminno@unina.it</email></corresp><fn id="fn1-0981495"><p>Giovanni Di Minno is Professor of Clinical Medicine and Chairman of the Department of Clinical Medicine and Surgery, “Federico II” University Hospital, Naples, Italy and President Elect of the Association of the Italian Haemophilia Centres (2014–2017). His main field of interest is immunotolerance induction and prevention of rheumatologic and psychological complications in patients with hemophilia. Mariana Canaro is Associate Doctor of Haematology at the Haemostasis and Thrombosis section and Haemophilia Unit at the Son Espases Universitary Hospital, Palma de Mallorca, Spain. Her main field of interest is treatment and Quality of Life in patients with hemophilia. James W. Ironside is Professor of Clinical Neuropathology and Head of the Laboratory Group in the National Creutzfeldt-Jakob Disease Research and Surveillance Unit, University of Edinburgh, Edinburgh, UK. His main field of interest is the characteristics and transmissibility of Creutzfeldt-Jakob disease and other human spongiform encephalopathies. David Navarro is Full Professor of Microbiology at the School of Medicine, University of Valencia and Head of Molecular Biology and Virology areas of the Microbiology Service, Hospital Clínico Universitario of Valencia, Valencia, Spain. His main field of interest is molecular and clinical virology, in particular concerning herpes viruses. Carlo F. Perno is Professor of Virology at the Department of Experimental Medicine and Surgery and Director of the Unit of Molecular Virology, University of Rome Tor Vergata, Rome, Italy. His main field of interest is antiviral therapy, advanced clinical diagnostics in virology and clinical interpretation of antiviral resistance testing. Andreas Tiede is Head of Hemostasis and Thrombosis at the Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. His main field of interest is treatment of hemophilia, acquired hemophilia and von Willebrand syndrome. Lutz Gürtler is Emeritus Professor at the Max von Pettenkofer Institute for Hygiene and Medical Microbiology, University of München, Munich, Germany. His main field of interests are virology, bacteriology and safety of blood supplies.</p></fn></author-notes><pub-date pub-type="ppub"><month>10</month><year>2013</year></pub-date><volume>98</volume><issue>10</issue><fpage>1495</fpage><lpage>1498</lpage><permissions><copyright-statement>Copyright© Ferrata Storti Foundation</copyright-statement><copyright-year>2013</copyright-year></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="981495.pdf"></self-uri></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000568 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000568 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:3789452
|texte= Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:24091928" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |